Airacof - 23359-019-16 - (CODEINE PHOSPHATE, PHENYLEPHRINE HYDROCHLORIDE AND DIPHENHYDRAMINE HYDROCHLORIDE)

Alphabetical Index


Drug Information of Airacof

Product NDC: 23359-019
Proprietary Name: Airacof
Non Proprietary Name: CODEINE PHOSPHATE, PHENYLEPHRINE HYDROCHLORIDE AND DIPHENHYDRAMINE HYDROCHLORIDE
Active Ingredient(s): 7.5; 12.5; 7.5    mg/5mL; mg/5mL; mg/5mL & nbsp;   CODEINE PHOSPHATE, PHENYLEPHRINE HYDROCHLORIDE AND DIPHENHYDRAMINE HYDROCHLORIDE
Administration Route(s): ORAL
Dosage Form(s): LIQUID
Coding System: National Drug Codes(NDC)

Labeler Information of Airacof

Product NDC: 23359-019
Labeler Name: CENTURION LABS, LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number:
Marketing Category: UNAPPROVED DRUG OTHER
Start Marketing Date: 20100108

Package Information of Airacof

Package NDC: 23359-019-16
Package Description: 473 mL in 1 BOTTLE, PLASTIC (23359-019-16)

NDC Information of Airacof

NDC Code 23359-019-16
Proprietary Name Airacof
Package Description 473 mL in 1 BOTTLE, PLASTIC (23359-019-16)
Product NDC 23359-019
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name CODEINE PHOSPHATE, PHENYLEPHRINE HYDROCHLORIDE AND DIPHENHYDRAMINE HYDROCHLORIDE
Dosage Form Name LIQUID
Route Name ORAL
Start Marketing Date 20100108
Marketing Category Name UNAPPROVED DRUG OTHER
Labeler Name CENTURION LABS, LLC
Substance Name CODEINE PHOSPHATE; DIPHENHYDRAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE
Strength Number 7.5; 12.5; 7.5
Strength Unit mg/5mL; mg/5mL; mg/5mL
Pharmaceutical Classes Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC]

Complete Information of Airacof


General Information